1. Mokdad A. A., Lopez A. D., Shahraz S., Lozano R., Mokdad A. H., Stanaway J., Murray Ch. J. L., Naghavi M. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Medicine, 2014, vol. 12, no. 1, 24 p. https://doi.org/10.1186/s12916-014-0145-y
2. Rummo O. O., Dzyadz’ko A. M., Fedoruk A. M., Shcherba A. E., Minov A. F. Organization of liver transplantation service in the Republic of Belarus. Transplantologiya [Transplantology], 2010, no. 1, pp. 68-71 (in Russian).
3. Lim Y.-S., Kim W. R. The global impact of hepatic fibrosis and end-stage liver disease. Clinics in Liver Disease, 2008, vol. 12, no. 4, pp. 733-746. https://doi.org/10.1016/j.cld.2008.07.007
4. Zatoński W. A., Sulkowska U., Mańczuk M., Rehm J., Boffetta P., Lowenfels A. B., La Vecchia C. Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe. European Addiction Research, 2010, vol. 16, no. 4, pp. 193-201. https://doi.org/10.1159/000317248
5. Minou A. F., Dzyadzko A. M., Shcherba A. E., Rummo O. O. The influence of pharmacological preconditioning with sevoflurane on incidence of early allograft dysfunction in liver transplant recipients. Anesthesiology Research and Practice, 2012, vol. 2012, 5 p. https://doi.org/10.1155/2012/930487
6. Shcherba A. E., Korotkov S. V., Minov A. F., Slobodin Yu. V., Savchuk M. M., Dzyadz’ko A. M., Rummo O. O. The effect of sevoflurane and acetylcysteine on ischemically-reperfusion damage of the donor liver with death of the brain. Vestnik transplantologii i iskusstvennykh organov [Bulletin of Transplantology and Artificial Organs], 2013, no. 1, pp. 39-44 (in Russian).
7. Method for assessing the risk of rejection and early dysfunction of liver transplants. Instruktsiya po primeneniyu : utverzhdena Ministerstvom zdravookhraneniya Respubliki Belarus’, 11 dekabrya 2015 g., № 181-1115 / A. E. Shcherba, S. V. Korotkov, D. Yu. Efimov, O. A. Lebed’, A. A. Koritko, A. I. Kireeva O. O. Rummo. Minsk, s. n., 2015. 8 p. (in Russian).
8. Minov A. F., Dzyadz’ko A. M. A method for diagnosing the risk of developing hemorrhagic syndrome or thrombotic complications. Patent Republic of Belarus no. 17630, 2013 (in Russian).
9. Shcherba A., Korotkov S., Efimov D., Minou A., Lebedz O., Karytka A., Fedaruk D., Santotsky E., Dzyadzko A., Rummo O. Portal and arterial flushing with HTK and tacrolimus can attenuate the incidence of early liver allograft dysfunction. Journal of Translational Medicine and Research, 2016, vol. 21, no. 2, pp. 109-115. https://doi.org/10.21614/jtmr-21-2-82
10. Minov A. F., Dzyadz’ko A. M., Shcherba A. E., Rummo O. O. Influence of the tactics of intensive therapy of hemostasis disorders on the intraoperative need for transfusion of blood components and the course of the postoperative period in liver transplantation. Novosti khirurgii [Surgery news], 2013, vol. 21, no. 3, pp. 69-78 (in Russian).
11. Dzyadz’ko A. M., Rummo O. O., Shcherba A. E., Minov A. F., Bolonkin L. S., Santotskii E. O., Chugunova O. A. Anesthesia and intensive therapy with hypothermic liver resections. First experience : materials of VII congress of anesthesiologists-resuscitators in the North-West of Russia. Efferentnaya terapiya [Efferent therapy], 2013, vol. 19, no. 2, p. 9 (in Russian).
12. IRODaT Newsletter 2013. IRODaT: International Registry in Organ Donation and Transplantation. Available at: http://www.irodat.org/img/database/grafics/newsletter/IRODaT Newsletter 2013 .pdf (accessed 16.01.2018).
Email this article 